REG - Hikma Pharmaceutical - Director/PDMR Shareholding

Hikma PharmaceuticalsAnnouncement

17/03/2021 14:30

RNS Number : 6098S
  
Hikma Pharmaceuticals Plc
  
17 March 2021
  
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities




1


Details of the person discharging managerial responsibilities / person closely associated




a)


Name


Mary Regina (Nina) Henderson




2


Reason for the notification




a)


Position/status


Non-executive Director




b)


Initial notification /Amendment


Initial notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Hikma Pharmaceuticals PLC




b)


LEI


549300BNS685UXH4JI75




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument and identification code


Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083




b)


Nature of the transaction
 


Market purchase of 1,600 Shares by Mary R Henderson Revocable Trust. 




c)


Price(s) and volume(s)


Price(s): £22.03
Volume(s): 1,600




d)


Aggregated information
-       Volume
-       Price
-       Total






 


 




1,600


 




£22.03


 




£35,248.00




e)


Date of the transaction


17 March 2021




f)


Place of the transaction


London Stock Exchange (XLON)




 
Peter Speirs

Company Secretary, responsible for releasing this announcement

+44 (0) 20 7399 2760
17 March 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DSHBSGDXIDBDGBR